{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T07:03:11Z","timestamp":1791442991045,"version":"4.3.3"},"reference-count":71,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Parasitology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.pt.2025.04.007","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T21:46:31Z","timestamp":1746740791000},"page":"431-440","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Antiparasitics discovery: from genotype to phenotype to compounds"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-8399-6430","authenticated-orcid":false,"given":"Richard J.","family":"Marh\u00f6fer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5185-0625","authenticated-orcid":false,"given":"Sandra","family":"Noack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6048-2636","authenticated-orcid":false,"given":"Paul M.","family":"Selzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pt.2025.04.007_bb0005","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0020-7519(98)00170-2","article-title":"Mechanism-based screening: discovery of the next generation of anthelmintics depends upon more basic research","volume":"29","author":"Geary","year":"1999","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.pt.2025.04.007_bb0010","series-title":"Antiparasitic and Antibacterial Drug Discovery: From Molecular Targets to Drug Candidates","first-page":"1","article-title":"Target identification and mechanism-based screening for anthelmintics: application of veterinary antiparasitic research programs to search for new antiparasitic drugs for human indications","volume":"1","author":"Geary","year":"2011"},{"key":"10.1016\/j.pt.2025.04.007_bb0015","series-title":"Apicomplexan Parasites: Molecular Approaches toward Targeted Drug Development","first-page":"1","article-title":"Drug discovery approaches toward anti-parasitic agents","author":"Rohwer","year":"2011"},{"key":"10.1016\/j.pt.2025.04.007_bb0020","series-title":"Parasitic Helminths: Targets, Screens, Drugs and Vaccines","first-page":"135","article-title":"Parasitic helminths","volume":"3","author":"Rohwer","year":"2012"},{"key":"10.1016\/j.pt.2025.04.007_bb0025","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nrd.2017.111","article-title":"Opportunities and challenges in phenotypic drug discovery: an industry perspective","volume":"16","author":"Moffat","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.pt.2025.04.007_bb0030","series-title":"Wirkstoffdesign","author":"Klebe","year":"2009"},{"key":"10.1016\/j.pt.2025.04.007_bb0035","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00253-15","article-title":"Target mechanism-based whole-cell screening identifies bortezomib as an inhibitor of caseinolytic protease in mycobacteria","volume":"6","author":"Moreira","year":"2015","journal-title":"mBio"},{"key":"10.1016\/j.pt.2025.04.007_bb0040","first-page":"95","article-title":"Animal metrics: tracking contributions of new approach methods to reduced animal use","volume":"39","author":"Marty","year":"2021","journal-title":"ALTEX"},{"key":"10.1016\/j.pt.2025.04.007_bb0045","series-title":"The Principles of Humans Experimental Technique","author":"Russell","year":"1959"},{"key":"10.1016\/j.pt.2025.04.007_bb0050","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3390\/ani9100754","article-title":"The 3Rs and humane experimental technique: implementing change","volume":"9","author":"Hubrecht","year":"2019","journal-title":"Animals"},{"key":"10.1016\/j.pt.2025.04.007_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056788","article-title":"Molecular dynamics reveal binding mode of glutathionylspermidine by trypanothione synthetase","volume":"8","author":"Koch","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pt.2025.04.007_bb0060","series-title":"Trypanosomatid Diseases: Molecular Routes to Drug Discovery","first-page":"429","article-title":"Trypanosomatid diseases","author":"Koch","year":"2013"},{"key":"10.1016\/j.pt.2025.04.007_bb0065","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.4155\/fmc.11.60","article-title":"Drug discovery and the use of computational approaches for infectious diseases","volume":"3","author":"Marh\u00f6fer","year":"2011","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.pt.2025.04.007_bb0070","series-title":"Antiparasitic and Antibacterial Drug Discovery: From Molecular Targets to Drug Candidates","first-page":"323","article-title":"Searching new antiparasitics in virtual space","volume":"1","author":"Oellien","year":"2011"},{"key":"10.1016\/j.pt.2025.04.007_bb0075","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2174\/1871520621666210908101751","article-title":"Naturally sourced CDK inhibitors and current trends in structure-based synthetic anticancer drug design by crystallography","volume":"22","author":"Nandi","year":"2021","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.pt.2025.04.007_bb0080","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.coph.2009.08.004","article-title":"Novel trends in high-throughput screening","volume":"9","author":"Mayr","year":"2009","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.pt.2025.04.007_bb0085","series-title":"Assay Guidance Manual 31, 2.02","first-page":"1151","article-title":"Interference with fluorescence","author":"Simeonov","year":"2004"},{"key":"10.1016\/j.pt.2025.04.007_bb0090","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1177\/24725552211008862","article-title":"Brief guide: experimental strategies for high-quality hit selection from small-molecule screening campaigns","volume":"26","author":"Rothenaigner","year":"2021","journal-title":"SLAS Discov."},{"key":"10.1016\/j.pt.2025.04.007_bb0095","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.drudis.2020.07.012","article-title":"Noncellular screening for the discovery of protein\u2013protein interaction modulators","volume":"25","author":"Kieffer","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.pt.2025.04.007_bb0100","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrd3480","article-title":"How were new medicines discovered?","volume":"10","author":"Swinney","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.pt.2025.04.007_bb0105","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nrd4336","article-title":"The discovery of first-in-class drugs: origins and evolution","volume":"13","author":"Eder","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.pt.2025.04.007_bb0110","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.pt.2023.01.010","article-title":"Drug discovery for parasitic diseases: powered by technology, enabled by pharmacology, informed by clinical science","volume":"39","author":"Rao","year":"2023","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.pt.2025.04.007_bb0115","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ibmb.2013.11.009","article-title":"The novel isoxazoline ectoparasiticide fluralaner: selective inhibition of arthropod \u03b3-aminobutyric acid- and l-glutamate-gated chloride channels and insecticidal\/acaricidal activity","volume":"45","author":"Gassel","year":"2014","journal-title":"Insect Biochem. Mol."},{"key":"10.1016\/j.pt.2025.04.007_bb0120","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.ijpara.2007.05.006","article-title":"The calcium-activated potassium channel, SLO-1, is required for the action of the novel cyclo-octadepsipeptide anthelmintic, emodepside, in Caenorhabditis elegans","volume":"37","author":"Guest","year":"2007","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.pt.2025.04.007_bb0125","doi-asserted-by":"crossref","first-page":"18873","DOI":"10.1074\/jbc.AC119.011093","article-title":"The anthelmintic drug praziquantel activates a schistosome transient receptor potential channel","volume":"294","author":"Park","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pt.2025.04.007_bb0130","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.pt.2019.11.002","article-title":"The journey to discovering a flatworm target of praziquantel: a long TRP","volume":"36","author":"Park","year":"2020","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.pt.2025.04.007_bb0135","doi-asserted-by":"crossref","first-page":"7015","DOI":"10.3390\/ijms25137015","article-title":"Inference of essential genes of the parasite Haemonchus contortus via machine learning","volume":"25","author":"Campos","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pt.2025.04.007_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008627","article-title":"CRISPR-mediated transfection of Brugia malayi","volume":"14","author":"Liu","year":"2020","journal-title":"PLoS Neglect. Trop. Dis."},{"key":"10.1016\/j.pt.2025.04.007_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000723","article-title":"Genetic and functional diversification of chemosensory pathway receptors in mosquito-borne filarial nematodes","volume":"18","author":"Wheeler","year":"2020","journal-title":"PLoS Biol."},{"key":"10.1016\/j.pt.2025.04.007_bb0150","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pt.2020.09.004","article-title":"Antiparasitics in animal health: quo vadis?","volume":"37","author":"Selzer","year":"2020","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.pt.2025.04.007_bb0155","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2174\/138620708785739952","article-title":"A ligand-based approach to mining the chemogenomic space of drugs","volume":"11","author":"Gregori-Puigjane","year":"2008","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"10.1016\/j.pt.2025.04.007_bb0160","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1021\/ci600300k","article-title":"Ligand-based approach to in silico pharmacology: nuclear receptor profiling","volume":"46","author":"Mestres","year":"2006","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.pt.2025.04.007_bb0165","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nbt1284","article-title":"Relating protein pharmacology by ligand chemistry","volume":"25","author":"Keiser","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.pt.2025.04.007_bb0170","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/978-1-4939-9145-7_6","article-title":"Target identification and validation in drug discovery, methods and protocols","volume":"1953","author":"Trosset","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.pt.2025.04.007_bb0175","unstructured":"Mita, T. et al. Nissan Chemical Industries. Isoxazoline-substituted benzamide compound and noxious organism control agent, WO2005085216A1"},{"key":"10.1016\/j.pt.2025.04.007_bb0180","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nature19339","article-title":"Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness","volume":"537","author":"Khare","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.pt.2025.04.007_bb0185","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/tropicalmed5010028","article-title":"Anti-trypanosomal proteasome inhibitors cure hemolymphatic and meningoencephalic murine infection models of African trypanosomiasis","volume":"5","author":"Rao","year":"2020","journal-title":"Trop. Med. Infect. Dis."},{"key":"10.1016\/j.pt.2025.04.007_bb0190","doi-asserted-by":"crossref","first-page":"9523","DOI":"10.1021\/acs.jmedchem.0c00705","article-title":"Identification and optimization of a series of 8-hydroxy naphthyridines with potent in vitro antileishmanial activity: initial SAR and assessment of in vivo activity","volume":"63","author":"Thomas","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pt.2025.04.007_bb0195","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/QCO.0b013e32833f9fd0","article-title":"Potential new drugs for human African trypanosomiasis; some progress at last","volume":"23","author":"Barrett","year":"2010","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.pt.2025.04.007_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007315","article-title":"The trypanocidal benzoxaborole AN7973 inhibits trypanosome mRNA processing","volume":"14","author":"Begolo","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.pt.2025.04.007_bb0205","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1021\/acsinfecdis.4c00020","article-title":"Dual strategy to design new agents targeting Schistosoma mansoni: advancing phenotypic and SmCB1 inhibitors for improved efficacy","volume":"10","author":"Fuchs","year":"2024","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.pt.2025.04.007_bb0210","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/cmdc.201500516","article-title":"Isoxazolines: a novel chemotype highly effective on ectoparasites","volume":"11","author":"Weber","year":"2016","journal-title":"Chemmedchem"},{"key":"10.1016\/j.pt.2025.04.007_bb0215","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.bbrc.2009.11.131","article-title":"The antiparasitic isoxazoline A1443 is a potent blocker of insect ligand-gated chloride channels","volume":"391","author":"Ozoe","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.pt.2025.04.007_bb0220","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1016\/j.bmcl.2013.03.031","article-title":"4-Azolylphenyl isoxazoline insecticides acting at the GABA gated chloride channel","volume":"23","author":"Lahm","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.pt.2025.04.007_bb0225","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.vetpar.2014.02.020","article-title":"Discovery and mode of action of afoxolaner, a new isoxazoline parasiticide for dogs","volume":"201","author":"Shoop","year":"2014","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.pt.2025.04.007_bb0230","unstructured":"Heckeroth, A.R. et al. Intervet International. Isoxazoline compositions and their use as antiparasitics, WO2009024541A2"},{"key":"10.1016\/j.pt.2025.04.007_bb0235","unstructured":"Long, J.K. et al. Du Pont. Naphthalene isoxazoline compounds for control of invertebrate pests; WO2009045999A1"},{"key":"10.1016\/j.pt.2025.04.007_bb0240","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1021\/tx400055p","article-title":"New GABA\/glutamate receptor target for [3H]isoxazoline insecticide","volume":"26","author":"Garc\u00eda-Reynaga","year":"2013","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.pt.2025.04.007_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.pestbp.2022.105217","article-title":"The mode of action of isocycloseram: a novel isoxazoline insecticide","volume":"187","author":"Blythe","year":"2022","journal-title":"Pestic. Biochem. Physiol."},{"key":"10.1016\/j.pt.2025.04.007_bb0250","series-title":"Abstracts of Papers","article-title":"Mode of action of the ectoparasiticide fluralaner: state-dependent inhibition of GABA receptor channels","author":"Ozoe","year":"2021"},{"key":"10.1016\/j.pt.2025.04.007_bb0255","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3390\/insects15050334","article-title":"Effects of RDL GABA receptor point mutants on susceptibility to meta-diamide and isoxazoline insecticides in Drosophila melanogaster","volume":"15","author":"Zhou","year":"2024","journal-title":"Insects"},{"key":"10.1016\/j.pt.2025.04.007_bb0260","series-title":"Abstract Book","article-title":"Tigolaner: innovation story of a new bispyrazole allosteric modulator of GABA-gated channel and its use as a spot-on ectoparasiticide in animal health","author":"Maue","year":"2023"},{"key":"10.1016\/j.pt.2025.04.007_bb0265","unstructured":"Marcel, J.P.J. et al. Syngenta Participations. Insecticidal Compounds, WO2012107434A1"},{"key":"10.1016\/j.pt.2025.04.007_bb0270","doi-asserted-by":"crossref","first-page":"692","DOI":"10.7164\/antibiotics.45.692","article-title":"A new anthelmintic cyclodepsipeptide, pf1022a","volume":"45","author":"Sasaki","year":"1992","journal-title":"J. Antibiotics"},{"key":"10.1016\/j.pt.2025.04.007_bb0275","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0960-894X(98)00156-5","article-title":"PF1022A \u2014 a novel anthelmintic cyclooctadepsipeptide. modification and exchange of the N-methyl leucine residues","volume":"8","author":"Scherkenbeck","year":"1998","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.pt.2025.04.007_bb0280","unstructured":"Ohyama, M. et al. Meiji Seika Kaisha. Process for producing cyclodepsipeptide compounds and novel cyclodepsipeptide, WO199805655A1"},{"key":"10.1016\/j.pt.2025.04.007_bb0285","doi-asserted-by":"crossref","DOI":"10.3389\/fpara.2024.1508167","article-title":"Emodepside: the anthelmintic\u2019s mode of action and toxicity","volume":"3","author":"Njeshi","year":"2024","journal-title":"Front. Parasitol."},{"key":"10.1016\/j.pt.2025.04.007_bb0290","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1096\/fj.00-0664fje","article-title":"Latrophilin-like receptor from the parasitic nematode Haemonchus contortus as target for the anthelmintic depsipeptide PF1022A","volume":"15","author":"Saeger","year":"2001","journal-title":"FASEB J."},{"key":"10.1016\/j.pt.2025.04.007_bb0295","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003401","article-title":"Characterization of the Ca2+-gated and voltage-dependent K+-channel Slo-1 of nematodes and its interaction with emodepside","volume":"8","author":"Kulke","year":"2014","journal-title":"Plos Neglect. Trop. Dis."},{"key":"10.1016\/j.pt.2025.04.007_bb0300","doi-asserted-by":"crossref","first-page":"7164","DOI":"10.1038\/s41467-021-27435-w","article-title":"Small molecule modulation of the Drosophila Slo channel elucidated by cryo-EM","volume":"12","author":"Raisch","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.pt.2025.04.007_bb0305","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1007\/s00436-005-1440-5","article-title":"Cyclohexadepsipeptides (CHDPs) with improved anthelmintical efficacy against the gastrointestinal nematode (Haemonchus contortus) in sheep","volume":"97","author":"Jeschke","year":"2005","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.pt.2025.04.007_bb0310","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009682","article-title":"Development of emodepside as a possible adulticidal treatment for human onchocerciasis\u2013the fruit of a successful industrial\u2013academic collaboration","volume":"17","author":"Kr\u00fccken","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.pt.2025.04.007_bb0315","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1056\/NEJMoa2212825","article-title":"Emodepside for Trichuris trichiura and hookworm infection","volume":"388","author":"Mrimi","year":"2023","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.pt.2025.04.007_bb0320","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2005.10.007","article-title":"Large-conductance, calcium-activated potassium channels: structural and functional implications","volume":"110","author":"Ghatta","year":"2006","journal-title":"Pharmacol. Therapeut."},{"key":"10.1016\/j.pt.2025.04.007_bb0325","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202300154","article-title":"Praziquantel \u2013 50 years of research","volume":"18","author":"Waechtler","year":"2023","journal-title":"ChemMedChem"},{"key":"10.1016\/j.pt.2025.04.007_bb0330","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abj5832","article-title":"Mechanism of praziquantel action at a parasitic flatworm ion channel","volume":"13","author":"Park","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.pt.2025.04.007_bb0335","doi-asserted-by":"crossref","DOI":"10.1038\/s41594-024-01298-3","article-title":"Target-based discovery of a broad spectrum flukicide","author":"Sprague","year":"2024","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.pt.2025.04.007_bb0340","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.exppara.2011.08.012","article-title":"Emodepside and SL0-1 potassium channels: a review","volume":"132","author":"Martin","year":"2012","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.pt.2025.04.007_bb0345","unstructured":"Griebenow, N. et al. Bayer. Substituted condensed azines as anthelmintic compounds, WO2021204930A1"},{"key":"10.1016\/j.pt.2025.04.007_bb0350","author":"CISS-CEESA Animal Health Market 2023Q2"},{"key":"10.1016\/j.pt.2025.04.007_bb0355","series-title":"Fabian Kausche reviews factors shaping animal health innovation","author":"Lazell","year":"2023"}],"container-title":["Trends in Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471492225001011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471492225001011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T08:05:22Z","timestamp":1750147522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471492225001011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":71,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1471492225001011"],"URL":"https:\/\/doi.org\/10.1016\/j.pt.2025.04.007","relation":{},"ISSN":["1471-4922"],"issn-type":[{"value":"1471-4922","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiparasitics discovery: from genotype to phenotype to compounds","name":"articletitle","label":"Article Title"},{"value":"Trends in Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pt.2025.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}